Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is a paper indexed in PICO Portal from OpenAlex.
How many citations does Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) have?
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) has 20 citations in the OpenAlex counts PICO Portal stores.
When was Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) published?
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) has 2021 year in the PICO Portal index.
What is the open-access status of Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) has hybrid oa status in the PICO Portal index.
What is the DOI of Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
The DOI for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is on the source record.
What is the PMID of Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
The PMID for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is on the source record.
What is the OpenAlex record for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>)?
The OpenAlex for Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, p<scp>lacebo‐controlled</scp> study (<scp>IRON</scp>‐<scp>CLAD</scp>) is on the source record.